A Study of AK111 in Healthy Subjects
NCT03622021
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
68
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
AK111 or Placebo
Sponsor
Akesobio Australia Pty Ltd